HASBROUCK HEIGHTS, N.J., Oct. 23, 2016 -- Patients can have a thorough evaluation that can identify signs of serious eye diseases at earlier stages than with other methods, reports Heights Eye Center. An appointment with a Hasbrouck Heights optometrist provides patients with the benefit of improved eye disease diagnosis and management for conditions including glaucoma, cataracts and macular degeneration. Optomap technology provides eye doctors and vision patients with enhanced diagnostic capabilities, and is performed without the need for pupil dilation. Heights Eye Center combines quality eye care with the latest technology for exceptional vision services and treatment.
Optomap retinal exams provide patients with enhanced accuracy in the early detection of eye diseases and health issues. An optomap image can provide data that goes beyond commonly diagnosed vision conditions, including cataracts, glaucoma and macular degeneration. An optomap retinal exam provides eye doctors with detailed imaging that can show early signs of those at risk of hypertension, heart disease, stroke and diabetes. The exam using an optomap retinal scanner is comfortable, quick and painless. A patient peers into the optomap space a single eye at a time and a flash of light indicates when the image is captured. Images are available for immediate review.
Traditional exams show very little of the actual retina, with eye doctors only seeing 15 percent of the retina in a single image. Optomap retinal scanning provides significantly more information to eye doctors and patients, capturing over 80 percent of the retina in one image. This data can detect signs of eye conditions sooner, which may prevent permanent vision impairment or blindness. Both children and adults can benefit from an optomap retinal exam.
“Optomap technology is a safe and effective tool to evaluate patient eye health and give important information on serious eye and health conditions,” said Dr. James Aversa. “As an experienced optometrist, I can share that optomap technology has allowed us improved capabilities of eye disease detection and eye health maintenance. This advanced scanning laser technology allows optometrists to examine the retina and capture a wide field digital image of eye structures and conditions. Optomap can be used safely and without discomfort on children and adults providing more information about a patient’s eye health. Early diagnosis helps patients and doctors work towards improved outcomes.”
Dr. James Aversa, optometrist in Hasbrouck Heights at Heights Eye Center, serves eye care needs of residents of Hasbrouck Heights and the surrounding area. Patients can expect comprehensive vision and eye care combined with the latest optical technology for the entire family. Services include non-surgical vision correction, dry eye treatment, Miboflo lid treatment, digital retinal photography, BlephEx, computerized visual field testing, LASIK evaluations and Gems genetic testing.
Call (201) 288-1109 to learn about optomap technology or visit http://www.heightseyecenter.net/ for more details on their eye care services.
Heights Eye Center, (201) 288-1109


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



